[1]金鹏,孙钢.对经皮椎体强化术的再认识[J].介入放射学杂志,2016,(06):463-468.
　JIN Peng,SUN Gang.Re-understanding of percutaneous vertebral augmentation [J].journal interventional radiology,2016,(06):463-468.
点击复制

对经皮椎体强化术的再认识()

PDF下载中关闭

  1. 1
  2. 2
  3. 3
分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2016年06期
页码:
463-468
栏目:
专 论
出版日期:
2016-06-25

文章信息/Info

Title:
Re-understanding of percutaneous vertebral augmentation

作者:
金鹏; 孙钢
Author(s):
JIN Peng;  SUN Gang
Department of Medical Imaging, General Hospital of Jinan Military Area Command, Jinan, Shandong Province 250031, China
关键词:
【关键词】椎体骨折;  系统评价;  椎体强化术
文献标志码:
A
摘要:
【摘要】多年来,以椎体成形术和椎体后凸成形术为代表的椎体强化术（PVA）已成功用于治疗骨质疏松性和肿瘤性椎体骨折。2009年发表于New England Journal of Medicine的两篇文章对椎体成形术治疗椎体压缩骨折的疗效提出质疑。然而随后大量的反驳文献陆续发表。PVA仍被广泛应用于临床。文章的目的是在临床参数（疼痛,残疾,生活质量,新发骨折）及影像学表现等方面,比较非手术治疗和PVA的治疗效果,讨论“非手术治疗失败”的定义和PVA骨水泥渗漏等不良反应。根据临床证据,探讨治疗骨质疏松性和肿瘤性椎体骨折最佳方案。


参考文献/References:

 

［1］Dittmer DK, Teasell R. Complications of immobilization and bed rest. Part 1: musculoskeletal and cardiovascular complications［J］. Can Fam Physician, 1993, 39: 1428-1432.

［2］Teasell R, Dittmer DK. Complications of immobilization and bed rest. Part 2: other complications［J］. Can Fam Physician, 1993, 39: 1440-1442.

［3］Cherasse A, Muller G, Ornetti P, et al. Tolerability of opioids in patients with acute pain due to nonmalignant musculoskeletal disease. A hospital-based observational study［J］. Joint Bone Spine, 2004, 71: 572-576.

［4］Brown CJ, Friedkin RJ, Inouye SK. Prevalence and outcomes of low mobility in hospitalized older patients［J］. J Am Geriatr Soc, 2004, 52: 1263-1270.

［5］Babayev M, Lachmann E, Nagler W. The controversy surrounding sacral insufficiency fractures: to ambulate or not to ambulate?［J］. Am J Phys Med Rehabil, 2000, 79: 404-409.

［6］Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial［J］. Ann Intern Med, 1995, 123: 241-249.

［7］Stalnikowicz R, Rachmilewitz D. NSAID-induced gastroduodenal damage: is prevention needed? A review and meta-analysis［J］. J Clin Gastroenterol, 1993, 17: 238-243.

［8］Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety［J］. Pain, 2004, 112: 372-380.

［9］Santiago FR, Abela AP, Alvarez LG, et al. Pain and functional outcome after vertebroplasty and kyphoplasty. A comparative study［J］. Eur J Radiol, 2010, 75: e108-e113.

［10］Sun G, Jin P, Li M, et al. Height restoration and wedge angle correction effects of percutaneous vertebroplasty: association with intraosseous clefts［J］. Eur Radiol, 2011, 21: 2597-2603.

［11］Rousing R, Hansen KL, Andersen MO, et al. Twelve-months follow-up in forty-nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study［J］. Spine (Phila Pa 1976), 2010, 35: 478-482.

［12］Rousing R, Andersen MO, Jespersen SM, et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study［J］. Spine (Phila Pa 1976), 2009, 34: 1349-1354.

［13］Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures［J］. N Engl J Med, 2009, 361: 569-579.

［14］Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures［J］. N Engl J Med, 2009, 361: 557-568.

［15］Klazen CA, Lohle PN, De Vries J, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos Ⅱ): an open-label randomised trial［J］. Lancet, 2010, 376: 1085-1092.

［16］Farrokhi MR, Alibai E, Maghami Z. Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures［J］. J Neurosurg Spine, 2011, 14: 561-569.

［17］Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial［J］. Lancet, 2009, 373: 1016-1024.

［18］Blattert TR, Jestaedt L, Weckbach A. Suitability of a calcium phosphate cement in osteoporotic vertebral body fracture augmentation: a controlled, randomized, clinical trial of balloon kyphoplasty comparing calcium phosphate versus polymethylmethacrylate［J］. Spine (Phila Pa 1976), 2009, 34: 108-114.

［19］Muto M, Perrotta V, Guarnieri G, et al. Vertebroplasty and kyphoplasty: friends or foes?［J］. Radiol Med, 2008, 113: 1171-1184.

［20］Fenoglio L, Cena P, Migliore E, et al. Vertebroplasty in the treatment of osteoporosis vertebral fractures: report on 52 cases［J］. J Endocrinol Invest, 2008, 31: 795-798.

［21］Gray LA, Rad AE, Gaughen JR, et al. Efficacy of percutaneous vertebroplasty for multiple synchronous and metachronous vertebral compression fractures［J］. AJNR Am J Neuroradiol, 2009, 30: 318-322.

［22］Masala S, Mammucari M, Angelopoulos G, et al. Percutaneous vertebroplasty in the management of vertebral osteoporotic fractures. Short-term, mid-term and long-term follow-up of 285 patients［J］. Skeletal Radiol, 2009, 38: 863-869.

［23］Voormolen MH, Mali WP, Lohle PN, et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study［J］. AJNR Am J Neuroradiol, 2007, 28: 555-560.

［24］Comstock BA, Sitlani CM, Jarvik JG, et al. Investigational vertebroplasty safety and efficacy trial (INVEST): patient-reported outcomes through 1 year［J］. Radiology, 2013, 269: 224-231.

［25］Barr JD, Jensen ME, Hirsch JA, et al. Position statement on percutaneous vertebral augmentation: a consensus statement developed by the Society of Interventional Radiology(SIR), American Association of Neurological Surgeons(AANS)and the Congress of Neurological Surgeons(CNS), American College of Radiology(ACR), American Society of Neuroradiology(ASNR), American Society of Spine Radiology(ASSR), Canadian Interventional Radiology Association(CIRA), and the Society of NeuroInterventional Surgery(SNIS)［J］. J Vasc Interv Radiol, 2014, 25: 171-181.

［26］McConnell CT, Wippold FJ, Ray CE, et al. ACR appropriateness criteria management of vertebral compression fractures［J］. J Am Coll Radiol, 2014, 11: 757-763.

［27］Klazen CA, Verhaar HJ, Lampmann LE, et al. VERTOS Ⅱ: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures: rationale, objectives and design of a multicenter randomized controlled trial［J］. Trials, 2007, 8: 33.

［28］Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture［J］. JAMA, 2001, 285: 320-323.

［29］Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) study group［J］. JAMA, 1999, 282: 1344-1352.

［30］Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) study group［J］. Osteoporos Int, 2000, 11: 83-91.

［31］Kanis JA, Barton IP, Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture［J］. Osteoporos Int, 2005, 16: 475-482.

［32］Mudano AS, Bian J, Cope JU, et al. Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study［J］. Osteoporos Int, 2009, 20: 819-826.

［33］Al-Ali F, Barrow T, Luke K. Vertebroplasty: what is important and what is not［J］. AJNR Am J Neuroradiol, 2009, 30: 1835-1839.

［34］Hierholzer J, Fuchs H, Westphalen K, et al. Incidence of symptomatic vertebral fractures in patients after percutaneous vertebroplasty［J］. Cardiovasc Intervent Radiol, 2008, 31: 1178-1183.

［35］Frankel BM, Monroe T, Wang C. Percutaneous vertebral augmentation: an elevation in adjacent-level fracture risk in kyphoplasty as compared with vertebroplasty［J］. Spine J, 2007, 7: 575-582.

［36］Eck JC, Nachtigall D, Humphreys SC, et al. Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature［J］. Spine J, 2008, 8: 488-497.

［37］Chang CY, Teng MM, Wei CJ, et al. Percutaneous vertebroplasty for patients with osteoporosis: a one-year follow-up［J］. Acta Radiol, 2006, 47: 568-573.

［38］Kasperk C, Grafe IA, Schmitt S, et al. Three-year outcomes after kyphoplasty in patients with osteoporosis with painful vertebral fractures［J］. J Vasc Interv Radiol, 2010, 21: 701-709.

［39］Sun G, Tang H, Li M, et al. Analysis of risk factors of subsequent fractures after vertebroplasty［J］. Eur Spine J, 2014, 23: 1339-1345.

［40］Chen LH, Hsieh MK, Liao JC, et al. Repeated percutaneous vertebroplasty for refracture of cemented vertebrae［J］. Arch Orthop Trauma Surg, 2011, 131: 927-933.

［41］Lin CC, Chen IH, Yen PS, et al. Repeat percutaneous vertebroplasty at cemented vertebra with fluid sign and recurrent pain［J］. Interv Neuroradiol, 2008, 14: 85-90.

［42］He SC, Teng GJ, Deng G, et al. Repeat vertebroplasty for unrelieved pain at previously treated vertebral levels with osteoporotic vertebral compression fractures［J］. Spine (Phila Pa 1976), 2008, 33: 640-647.

［43］Li L, Lu Y, Li M, et al. Repeat percutaneous vertebroplasty for recurrent pain arising from previously treated vertebrae in patients with osteoporotic vertebral compression fractures［J］. Clin Spine Surg, 2016 ［Epub ahead of print］

［44］Voormolen M, Van Rooij WJ, Sluzewski M, et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema［J］. AJNR Am J Neuroradiol, 2006, 27: 1579-1585.

［45］中华医学会放射学分会介入学组. 经皮椎体成形术操作技术专家共识［J］. 中华放射学杂志,2014,48： 6-9.

［46］王宏伟,何仕诚,滕皋军,等. 经皮椎体成形术治疗椎体转移性肿瘤的疗效分析［J］. 介入放射学杂志,2010,19： 784-787.

［47］Liu XW, Jin P, Wang LJ, et al. Vertebroplasty in the treatment of symptomatic vertebral haemangiomas without neurological deficit［J］. Eur Radiol, 2013, 23: 2575-2581.

［48］Berenson J, Plugmacher R, Jarzem P, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multi-centre, randomized controlled trial［J］. Lancet Oncol, 2011, 12: 225-235.

［49］ Jay B, Ahn SH. Vertebroplasty［J］. Semin Intervent Radiol, 2013, 30: 297-306.

［50］ Denaro V, Longo UG, Maffulli N, et al. Vertebroplasty and kyphoplasty［J］. Clin Cases Miner Bone Metab, 2009, 6: 125-130.

［51］Puri AS, Erdem E. Salvage percutaneous vertebral augmentation in failed spinal interbody fusions associated with multiple myeloma［J］. Spine J, 2010, 10: e5-e10.

［52］Yamana K, Tanaka M, Sugimoto Y, et al. Clinical application of a pedicle nail system with polymethylmethacrylate for osteoporotic vertebral fracture［J］. Eur Spine J, 2010, 19: 1643-1650.

［53］Frankel BM, Jones T, Wang C. Segmental polymethylmethacrylate-augmented pedicle screw fixation in patients with bone softening caused by osteoporosis and metastatic tumor involvement: a clinical evaluation［J］. Neurosurgery, 2007, 61: 531-537.

 

相似文献/References:

[1]唐世伟,陈 俊,王忠敏,等.介入栓塞术对比手术治疗有症状子宫肌瘤安全性及有效性的meta分析[J].介入放射学杂志,2015,(03):200.
　TANG Shi wei,CHEN Jun,WANG Zhong min,et al.Interventional embolization and surgery for the treatment of symptomatic uterine fibroids： a meta analysis of the safety and effectiveness[J].journal interventional radiology,2015,(06):200.
[2]李 征,米登海,杨克虎,等.经动脉化疗栓塞联合微波消融治疗肝癌有效性和安全性的系统评价[J].介入放射学杂志,2015,(11):957.
　LI Zheng,MI Deng- hai,YANG Ke- hu,et al.Effectiveness and safety of TACE combined with MWA for primary hepatic cancer： a systematic review[J].journal interventional radiology,2015,(06):957.
[3]唐世伟,赵新建,王忠敏,等.TIPS对比EBL治疗肝硬化食管静脉曲张出血Meta分析[J].介入放射学杂志,2016,(09):761.
　TANG Shi- wei,ZHAO Xin- jian,WANG Zhong- min,et al.The treatment of cirrhosis esophageal variceal bleeding： a meta- analysis of TIPS versus EBL[J].journal interventional radiology,2016,(06):761.
[4]洪子强,白向豆,崔百强,等.经皮射频消融与微波消融治疗肺癌有效性及安全性的Meta分析 [J].介入放射学杂志,2023,32(04):341.
　HONG Ziqiang,BAI Xiangdou,CUI Baiqiang,et al.The effectiveness and safety of percutaneous radiofrequency ablation versus microwave ablation in the treatment of lung cancer： a meta analysis[J].journal interventional radiology,2023,32(06):341.
[5]王秀蓓,王海芳,沈静慧.肝硬化患者消化道出血风险预测模型的系统评价[J].介入放射学杂志,2023,32(09):918.
　WANG Xiubei,WANG Haifang,SHEN Jinghui..Systematic assessment of gastrointestinal bleeding risk prediction models for cirrhosis patients[J].journal interventional radiology,2023,32(06):918.

备注/Memo

备注/Memo:
(收稿日期：2015-12-16)
(本文编辑：俞瑞纲)
更新日期/Last Update: 2016-06-21